MEBUF(MEBUF)
MEBUF
No analyst ratings available
No analyst price targets available for MEBUF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $250.46B | $289.03B | $386.03B | $251.41B |
| Low | $238.02B | $262.37B | $366.87B | $238.92B |
| High | $262.89B | $315.68B | $405.20B | $263.89B |
| EBITDA Avg | $66.77B | $77.05B | $102.91B | $67.02B |
| Low | $63.46B | $69.95B | $97.80B | $63.70B |
| High | $70.09B | $84.16B | $108.02B | $70.35B |
| EBIT Avg | $59.03B | $68.12B | $90.99B | $59.26B |
| Low | $56.10B | $61.84B | $86.47B | $56.31B |
| High | $61.96B | $74.41B | $95.50B | $62.20B |
| Net Income Avg | $636M | $752M | $794M | $695M |
| Low | $595M | $703M | $742M | $650M |
| High | $677M | $800M | $845M | $740M |
| EPS Avg | $106.82 | $126.27 | $133.31 | $116.75 |
| Low | $99.93 | $118.12 | $124.70 | $109.21 |
| High | $113.72 | $134.42 | $141.91 | $124.28 |
| Analysts (Rev / EPS) | 1 / 1 | 2 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $107.40B | $111.01B |
| Low | $107.40B | $111.01B |
| High | $107.40B | $111.01B |
| EBITDA Avg | $28.63B | $29.59B |
| Low | $28.63B | $29.59B |
| High | $28.63B | $29.59B |
| EBIT Avg | $25.31B | $26.16B |
| Low | $25.31B | $26.16B |
| High | $25.31B | $26.16B |
| Net Income Avg | $25.22B | $27.68B |
| Low | $25.22B | $27.68B |
| High | $25.22B | $27.68B |
| EPS Avg | $26.88 | $29.51 |
| Low | $26.88 | $29.51 |
| High | $26.88 | $29.51 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |